Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-05-17 | Amended | $7,800,004 | $4,800,002 | Equity Only | 06b | SEC link |
| 2023-06-02 | New | $3,000,002 | $3,000,002 | Equity Only | 06b | SEC link |
| 2022-02-02 | New | $7,108,361 | $7,108,361 | Equity Only | 06b | SEC link |
| 2021-10-08 | New | $8,007,235 | $8,007,235 | Equity Only | 06b | SEC link |
| 2020-12-21 | New | $500,000 | $500,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Thomas Hennessey | Director |
| Xutian Jing | Director |
| Howard Rosen | Director |
| Nan Shen | Director |
| Jake Xia | Director |
| Qiaobing Xu | Director, Executive |